Enveric Biosciences logo

Enveric BiosciencesNASDAQ: ENVB

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

04 May 2015

Next earnings report:

13 November 2024

Last dividends:

23 April 2008

Next dividends:

N/A
$4.46 M
-93%vs. 3y high
12%vs. sector
-vs. 3y high
-vs. sector
-81%vs. 3y high
37%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Fri, 01 Nov 2024 22:42:04 GMT
$0.50-$0.03(-4.78%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

ENVB Latest News

Why Is Enveric Biosciences (ENVB) Stock Up 18% Today?
investorplace.com30 July 2024 Sentiment: POSITIVE

Enveric Biosciences (NASDAQ: ENVB ) stock is heading higher on Tuesday alongside heavy pre-market trading of the biotechnology company's shares. This comes with more than 13 million shares of ENVB stock changing hands as of this writing.

Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)
globenewswire.com28 June 2024 Sentiment: POSITIVE

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB). The update note includes information on the Enveric Bioscience's management commentary, recent developments, outlook, and risks.

Enveric Biosciences, Inc. (ENVB) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks Investment Research02 May 2024 Sentiment: NEGATIVE

Enveric Biosciences, Inc. (ENVB) closed at $0.93 on the most recent trading day, showing a decrease of 0.46% from its previous closing price.

Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors
Zacks Investment Research26 April 2024 Sentiment: NEUTRAL

Enveric Biosciences, Inc. (ENVB) ended the latest trading day at $0.90, down 0.56% from the day before.

What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock
Zacks Investment Research12 April 2024 Sentiment: POSITIVE

Enveric Biosciences (ENVB) could see an increase in its stock price due to increasing optimism about its earnings potential, as indicated by its upgrade to a Zacks Rank #1 (Strong Buy).

New Strong Buy Stocks for April 12th
Zacks Investment Research12 April 2024 Sentiment: POSITIVE

On April 12, 2024, ZUO, INTZ, SIGA, ENVB, and NTRS were included in the Zacks Rank #1 (Strong Buy) List.

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?
InvestorPlace29 February 2024 Sentiment: POSITIVE

Biotech investors know that small companies can make massive moves on big headlines, and we're seeing such a move in Enveric Biosciences (NASDAQ: ENVB ) today. Shares of ENVB stock are up more than 120% in early afternoon trading today after the company put forward a press release highlighting plans to license three classes of its compounds.

Bears are Losing Control Over Enveric Biosciences, Inc. (ENVB), Here's Why It's a 'Buy' Now
Zacks Investment Research20 December 2023 Sentiment: POSITIVE

Enveric Biosciences, Inc. (ENVB) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?
InvestorPlace18 May 2023 Sentiment: POSITIVE

Enveric Biosciences (NASDAQ: ENVB ) stock is enlivened amid an otherwise soft early afternoon session on Wall Street, delivering triple-digit percentage gains. Specializing in the development of novel small-molecule therapeutics for depression, anxiety and addiction disorders, Enveric just received positive regulatory news.

What type of business is Enveric Biosciences?

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

What sector is Enveric Biosciences in?

Enveric Biosciences is in the Healthcare sector

What industry is Enveric Biosciences in?

Enveric Biosciences is in the Biotechnology industry

What country is Enveric Biosciences from?

Enveric Biosciences is headquartered in United States

When did Enveric Biosciences go public?

Enveric Biosciences initial public offering (IPO) was on 04 May 2015

What is Enveric Biosciences website?

https://www.enveric.com

Is Enveric Biosciences in the S&P 500?

No, Enveric Biosciences is not included in the S&P 500 index

Is Enveric Biosciences in the NASDAQ 100?

No, Enveric Biosciences is not included in the NASDAQ 100 index

Is Enveric Biosciences in the Dow Jones?

No, Enveric Biosciences is not included in the Dow Jones index

When was Enveric Biosciences the previous earnings report?

No data

When does Enveric Biosciences earnings report?

The next expected earnings date for Enveric Biosciences is 13 November 2024